Safety and Immunogenicity of an Inactivated Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine in a Subgroup of Healthy Adults in Chile. - Bueno SM; Abarca K; González PA; Gálvez NMS; Soto JA; Duarte LF; Schultz BM; Pacheco GA; González LA; Vázquez Y; Ríos M; Melo-González F; et al. (Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2022)